(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	-
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

Pittsburgh Law Office of Alfred G. Yates Jr., PC Announces Investigation of Carbylan Therapeutics, Inc. (CBYL)

January 19, 2017

Research Reports Coverage on Generic Drugs Stocks -- SCYNEXIS, Supernus Pharma, Lipocine, and Carbylan Therapeutics

October 05, 2016

Performance

More News

Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan Therapeutics, Inc.; Encourages Investors to Contact the Firm

September 23, 2016

Carbylan Therapeutics enters agreement with KalVista Pharmaceuticals

June 15, 2016

Research Report Initiation on Generic Drugs Makers Stocks -- Ironwood Pharma, The Medicines, Carbylan Therapeutics, and Pacira Pharma

August 24, 2016

Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed Transaction

June 22, 2016

Higher open as producer prices rise

June 15, 2016

Lower close as trade deficit climbs

June 03, 2016

Carbylan Therapeutics, Inc. and KalVista Pharmaceuticals Ltd. Enter into Share Purchase Agreement

June 15, 2016

Why Investors Have This Drug Makers' Stocks on Their Radar? - Carbylan Therapeutics, Catalent Inc., Medicines Co., and Diplomat Pharmacy

June 06, 2016

BRIEF-Carbylan purported class action complaint was filed against it

September 30, 2016

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.